FDA DEVICE FACTS
Biodegradable Powder Free Nitrile Examination Glove, Blue Color, Tested for use with Chemotherapy drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl Citrate-Simulated Gastric Acid Solution
Sw Technologies, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. Chemotherapy Drug and Concentration — Breakthrough times in minutes per ASTM D6978-05 (2019):
- Carmustine (BCNU), 3.3 mg/ml — 86.3
- Cisplatin, 1.0 mg/ml — >240
- Cyclophosphamide (Cytoxan), 20 mg/ml — >240
- Dacarbazine (DTIC), 10 mg/ml — >240
- Doxorubicin Hydrochloride, 2.0 mg/ml — >240
- Etoposide (Toposar), 20 mg/ml — >240
- Fluorouracil, 50 mg/ml — >240
- Paclitaxel (Taxol), 6.0 mg/ml — >240
- Thiotepa, 10 mg/ml — 89.3
- Bleomycin Sulfate, 15 mg/ml (15,000 ppm) — >240
- Busulfan, 6 mg/ml (6,000 ppm) — >240
- Carboplatin, 10 mg/ml (10,000 ppm) — >240
- Cytarabine, 100 mg/ml (100,000 ppm) — >240
- Daunorubicin HCl, 5 mg/ml (5,000 ppm) — >240
- Docetaxel HCl, 10 mg/ml (10,000 ppm) — >240
- Epirubicin HCl (Ellence), 2 mg/ml (2,000 ppm) — >240
- Fludarabine Phosphate, 25 mg/ml (25,000 ppm) — >240
- Gemcitabine HCl, 38 mg/ml (38,000 ppm) — >240
- Idarubicin HCl, 1 mg/ml (1,000 ppm) — >240
- Mechlorethamine HCl, 1 mg/ml (1,000 ppm) — >240
- Melphalan HCl, 5 mg/ml (5,000 ppm) — >240
- Methotrexate, 25 mg/ml (25,000 ppm) — >240
- Mitomycin C, 0.5 mg/ml (500 ppm) — >240
- Mitoxantrone HCl, 2 mg/ml (2,000 ppm) — >240
- Oxaliplatin, 2 mg/ml (2,000 ppm) — >240
- Rituximab, 10 mg/ml (10,000 ppm) — >240
- Trisenox (Arsenic Trioxide), 1 mg/ml (1,000 ppm) — >240
- Vincristine Sulfate, 1 mg/ml (1,000 ppm) — >240
- Vinorelbine, 10 mg/ml (10,000 ppm) — >240
- Ifosfamide (50.0 mg/ml) — >240
- Irinotecan (20.0 mg/ml) — >240
- Fentanyl Citrate 100 mcg/2 ml — >240
- Simulated Gastric Acid — >240
- Fentanyl-Simulated Gastric Acid Solution 50/50 — >240 Caution: Please note low permeation times for Carmustine at 86.3 minutes and Thiotepa at 89.3 minutes.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。